Riluzole Oral Soluble Film ( DrugBank: Riluzole )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
2	Amyotrophic lateral sclerosis	2

2. Amyotrophic lateral sclerosis

---

Clinical trials : 624 /  Drugs : 611 - (DrugBank : 160) / Drug target genes : 172 - Drug target pathways : 225

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03679975 (ClinicalTrials.gov)	April 4, 2018	19/9/2018	Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS)	A Single Center Study to Evaluate the Effect of Riluzole Oral Soluble Film on Swallowing Safety in Individuals With Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Drug: Riluzole Oral Soluble film (ROSF) 50 mg	Aquestive Therapeutics	inVentiv Health Clinical;Covance	Terminated	18 Years	80 Years	All	9	Phase 2	United States
2	NCT03457753 (ClinicalTrials.gov)	March 1, 2018	26/2/2018	Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis	A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.	ALS	Drug: Riluzole Oral Soluble Film	Aquestive Therapeutics	Inventiv Health;Covance	Withdrawn	18 Years	80 Years	All	0	Phase 2	United States